These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16621242)

  • 21. [Correlation between studies and general practice].
    MMW Fortschr Med; 2006 Nov; 148(46):49. PubMed ID: 17615791
    [No Abstract]   [Full Text] [Related]  

  • 22. Preventing osteoporosis-related fractures: an overview.
    Gass M; Dawson-Hughes B
    Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 24. [Osteoporosis in the patients with rheumatoid arthritis (3) : the efficacy and the selection of the osteoporosis therapeutic drug].
    Nakayama H
    Clin Calcium; 2007 Oct; 17(10):1607-12. PubMed ID: 17906416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis prevention and treatment.
    Sambrook PN; Eisman JA
    Med J Aust; 2000 Mar; 172(5):226-9. PubMed ID: 10776395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.
    Chevalier Y; Quek E; Borah B; Gross G; Stewart J; Lang T; Zysset P
    Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
    Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Gentilella R; Agnusdei D; Iori N; Nuti R;
    J Bone Miner Res; 2006 Oct; 21(10):1565-70. PubMed ID: 16995811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of corticosteroid-induced osteoporosis].
    Orcel P
    Presse Med; 2006 Oct; 35(10 Pt 2):1571-7. PubMed ID: 17028523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Curtis JR; Saag KG
    Curr Osteoporos Rep; 2007 Mar; 5(1):14-21. PubMed ID: 17320023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis in men.
    Lems WF; Geusens PP
    N Engl J Med; 2008 Aug; 359(8):868; author reply 869. PubMed ID: 18724402
    [No Abstract]   [Full Text] [Related]  

  • 32. Web of industry, advocacy, and academia in the management of osteoporosis.
    Grey A; Bolland M
    BMJ; 2015 Jul; 351():h3170. PubMed ID: 26198274
    [No Abstract]   [Full Text] [Related]  

  • 33. [Osteoporosis management in general practice. Preventing spontaneous bone fractures].
    MMW Fortschr Med; 2010 Jul; 152(25-27):54-5. PubMed ID: 20672666
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combination treatment in osteoporosis. Basic treatment plus specific osteoporosis medication].
    Ringe JD
    Med Monatsschr Pharm; 2009 Apr; 32(4):137-40. PubMed ID: 19445270
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
    Hershman D; Narayanan R
    Curr Oncol Rep; 2004 Jul; 6(4):277-84. PubMed ID: 15161581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe osteoporosis with vertebral crushes in juvenile dermatomyositis. Effect of oral alendronate therapy].
    Tau C; Russo R
    Medicina (B Aires); 2007; 67(1):53-6. PubMed ID: 17408022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis in men.
    Cefalu CA
    Am Fam Physician; 2001 Jun; 63(12):2331-2. PubMed ID: 11430449
    [No Abstract]   [Full Text] [Related]  

  • 38. Risedronate: a new bisphosphonate for the treatment of osteoporosis.
    Kessenich CR
    Nurse Pract; 2000 Mar; 25(3):106-8. PubMed ID: 10750124
    [No Abstract]   [Full Text] [Related]  

  • 39. [Guidelines for the diagnosis, prevention and treatment of osteoporosis. Italian Osteoporosis, Mineral Metabolism, and Skeletal Diseases Society].
    Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
    Minerva Endocrinol; 2013 Mar; 38(1 Suppl 1):1-30. PubMed ID: 23539106
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.